ABBV Latest Headlines

2 ‘Strong Buy’ Dividend Aristocrat Stocks to Grab Right Now for August Payouts

at www.tipranks.com (Fri, 10-Jul 7:36 PM)

2 ‘Strong Buy’ Dividend Aristocrat Stocks to Pick Up Right Now for August Payouts

at www.tipranks.com (Fri, 10-Jul 7:36 PM)

2 ‘Strong Buy’ Dividend Aristocrat Stocks to Buy Right Now for August Payouts

at www.tipranks.com (Fri, 10-Jul 7:36 PM)

Catalyst Watch: Bank earnings, Netflix results, Alzheimer's conference

at seekingalpha.com (Fri, 10-Jul 3:00 PM)

ClearBridge International Growth Strategy: Adds ABB, BUD; exits SAP, Wuxi AppTec in Q2

at seekingalpha.com (Fri, 10-Jul 12:26 PM)

HSBC's top picks heading into earnings season

at seekingalpha.com (Fri, 10-Jul 9:18 AM)

Dividend Roundup: Costco, Phillips 66, Abbott Labs, AbbVie, and more

at seekingalpha.com (Fri, 10-Jul 8:25 AM)

Dividend Roundup: Costco, Phillips 66, Abbot Labs, AbbVie, and more

at seekingalpha.com (Fri, 10-Jul 8:25 AM)

Analysts Offer Insights on Healthcare Companies: TruBridge (TBRG), AbbVie (ABBV) and Nurix Therapeutics (NRIX)

at www.tipranks.com (Fri, 10-Jul 7:40 AM)

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Eli Lilly & Co (LLY)

at www.tipranks.com (Fri, 10-Jul 6:40 AM)

Wells Fargo Sticks to Their Buy Rating for AbbVie (ABBV)

at www.tipranks.com (Fri, 10-Jul 5:55 AM)

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Corcept Therapeutics (CORT)

at www.tipranks.com (Thu, 9-Jul 8:30 AM)

AbbVie’s TEPKINLY Combination Gains EU Approval, Marking 79% Reduced Disease Progression Risk for Follicular Lymphoma

Market Chameleon (Tue, 7-Jul 8:11 AM)

AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Move, Expanding Leadership in Immunology

Market Chameleon (Mon, 22-Jun 7:52 AM)

AbbVie’s Nine-Year CLL Data Signals Durable Treatment Benefits for Patients Using Venetoclax Combinations

Market Chameleon (Fri, 12-Jun 11:34 AM)

AbbVie’s Immunology and Neuroscience Units Fuel Double-Digit Revenue Growth in Q1 2026; Full-Year Outlook Raised

Market Chameleon (Wed, 29-Apr 8:26 AM)

AbbVie’s Expanded SKYRIZI FDA Application Could Offer Flexible Crohn’s Induction—Positive AFFIRM Study Data Backs Filing

Market Chameleon (Mon, 27-Apr 8:14 AM)